Dr. Lal PathLabs Croissance future
Future contrôle des critères 3/6
Dr. Lal PathLabs devrait augmenter ses bénéfices et son chiffre d'affaires de 13.6% et de 10.9% par an respectivement. Le BPA devrait croître de de 13.6% par an. Le rendement des capitaux propres devrait être 22% dans 3 ans.
Informations clés
13.6%
Taux de croissance des bénéfices
13.6%
Taux de croissance du BPA
| Healthcare croissance des bénéfices | 27.4% |
| Taux de croissance des recettes | 10.9% |
| Rendement futur des capitaux propres | 22.0% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 13 Nov 2024 |
Mises à jour récentes de la croissance future
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results
Oct 26
Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Recent updates
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results
Oct 26Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong
Oct 24Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk
Oct 06These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Jul 28We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve
May 21What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You
May 01Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 3/31/2027 | 31,170 | 5,897 | 6,645 | 7,167 | 21 |
| 3/31/2026 | 27,786 | 5,058 | 5,797 | 6,333 | 22 |
| 3/31/2025 | 24,796 | 4,362 | 4,996 | 5,511 | 20 |
| 9/30/2024 | 23,464 | 4,014 | 4,912 | 5,365 | N/A |
| 6/30/2024 | 22,875 | 3,815 | N/A | N/A | N/A |
| 3/31/2024 | 22,266 | 3,577 | 4,779 | 5,353 | N/A |
| 12/31/2023 | 21,722 | 3,298 | N/A | N/A | N/A |
| 9/30/2023 | 21,227 | 3,013 | 4,767 | 5,198 | N/A |
| 6/30/2023 | 20,552 | 2,638 | N/A | N/A | N/A |
| 3/31/2023 | 20,169 | 2,388 | 4,115 | 4,560 | N/A |
| 12/31/2022 | 20,114 | 2,435 | N/A | N/A | N/A |
| 9/30/2022 | 20,189 | 2,480 | -824 | 3,884 | N/A |
| 6/30/2022 | 19,835 | 2,713 | N/A | N/A | N/A |
| 3/31/2022 | 20,874 | 3,448 | -294 | 4,467 | N/A |
| 12/31/2021 | 20,329 | 3,669 | N/A | N/A | N/A |
| 9/30/2021 | 19,884 | 4,041 | 4,609 | 5,327 | N/A |
| 6/30/2021 | 19,219 | 3,944 | N/A | N/A | N/A |
| 3/31/2021 | 15,813 | 2,916 | 3,386 | 3,982 | N/A |
| 12/31/2020 | 14,520 | 2,407 | N/A | N/A | N/A |
| 9/30/2020 | 13,275 | 2,003 | 2,259 | 2,821 | N/A |
| 6/30/2020 | 12,612 | 1,955 | N/A | N/A | N/A |
| 3/31/2020 | 13,304 | 2,259 | 2,043 | 2,839 | N/A |
| 12/31/2019 | 13,298 | 2,405 | N/A | N/A | N/A |
| 9/30/2019 | 12,944 | 2,322 | 2,199 | 2,619 | N/A |
| 6/30/2019 | 12,463 | 2,086 | N/A | N/A | N/A |
| 3/31/2019 | 12,034 | 1,992 | 1,765 | 2,185 | N/A |
| 12/31/2018 | 11,691 | 1,923 | N/A | N/A | N/A |
| 9/30/2018 | 11,393 | 1,825 | N/A | N/A | N/A |
| 6/30/2018 | 10,999 | 1,761 | N/A | N/A | N/A |
| 3/31/2018 | 10,569 | 1,707 | N/A | 1,971 | N/A |
| 12/31/2017 | 10,100 | 1,617 | N/A | N/A | N/A |
| 9/30/2017 | 9,548 | 1,565 | N/A | N/A | N/A |
| 6/30/2017 | 9,389 | 1,586 | N/A | N/A | N/A |
| 3/31/2017 | 9,124 | 1,546 | N/A | 1,713 | N/A |
| 12/31/2016 | 8,902 | 1,576 | N/A | N/A | N/A |
| 9/30/2016 | 8,713 | 1,876 | N/A | N/A | N/A |
| 6/30/2016 | 8,249 | 1,413 | N/A | N/A | N/A |
| 3/31/2016 | 7,913 | 1,322 | N/A | 1,585 | N/A |
| 12/31/2015 | 7,654 | 1,201 | N/A | N/A | N/A |
| 3/31/2015 | 6,596 | 908 | N/A | 1,218 | N/A |
| 3/31/2014 | 5,579 | 763 | N/A | 980 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de LALPATHLAB ( 13.6% par an) est supérieure au taux d'épargne ( 6.7% ).
Bénéfices vs marché: Les bénéfices de LALPATHLAB ( 13.6% par an) devraient croître plus lentement que le marché Indian ( 18.1% par an).
Croissance élevée des bénéfices: Les bénéfices de LALPATHLAB devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de LALPATHLAB ( 10.9% par an) devrait croître plus rapidement que le marché Indian ( 10.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de LALPATHLAB ( 10.9% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de LALPATHLAB devrait être élevé dans 3 ans ( 22 %)